Thank you, Presiding Officer. The noise in the public gallery is probably just my family getting overexcited at the thought of me debating here today.
Most members will know that my connection with multiple sclerosis is through my wife Stacey, who, as members can see, is up in the public gallery. It is almost like “Romeo and Juliet”, with her up there on the balcony—and, yes, we are that romantic with each other. When Stacey was diagnosed at 16, that was a life-changing experience for her. Nobody knew about MS and she had to see general practitioners and consultants, so everything was difficult. Her family instantly went into a panic and did not understand what MS was. Her father, Tom, just thought, “Oh, now we know it’s MS.” It was only when her mother explained to him the life-changing aspect of MS that he understood and just broke down.
However, Stacey went on to university and, obviously, she eventually met the love of her life, so things got a lot better. Stacey is very positive about her MS, as is just about everybody I know who has it. I do not think that I have met one individual with MS who complains or moans about their situation. They want to be part of everything and to get on with stuff.
I apologise to my MSP colleagues for Stacey being the MS Society badge police for the past week. She has made sure that just about everyone has worn the badge. In fact, Rebecca Duff from the MS Society Scotland said, “I’m just glad she’s on our side, because I wouldn’t like to be on the other side.” That is how passionate Stacey is about making sure that we get the message out there. Sometimes, MS is not as high up the agenda as it should be.
Here we are in year 3 of Stacey’s annual MS awareness week debate. At the MS Society event in the Parliament last night, I talked to many families who are dealing with MS. My family has come here, too—they almost treat it as a busman’s holiday when they come over to see the debate.
My mother-in-law does this thing where she says, “You know, if someone stopped me in Paisley High Street about”—insert whatever subject—“I would say this.” That normally means that I have to listen, as she is trying to influence my opinion on various things that are happening in the world. She has said that a few times. When we discussed MS, we said that some of the problems for families who deal with MS are the shock, feeling alone and the ignorance of not knowing what MS is. Things have changed quite a bit and are moving forward, but those are still issues for many families.
Since last year, things have moved on quite a bit, with the creation of the cross-party group in the Scottish Parliament on MS. I see that my deputy convener on the group, Lewis Macdonald, is in the chamber. In creating an agenda, we ensured that we focused on what we can achieve, so that we have a work programme that can deliver something. We want to ensure that we do not just sit every quarter talking—in effect, moaning—about things not happening. That has been because the MS Society, partner organisations and other people who are involved with MS and who want to make a difference have got involved with the Government and the Parliament. That is the big difference for us.
Yesterday, Neil Findlay made the important point to me that many MSPs have a family member who has MS. That is an example or representation of what we are dealing with in Scotland.
At the first meeting of the cross-party group we started talking about access to medicines, which is currently a big, big issue. We need the pharmaceutical companies, the Scottish Government, partner organisations and the national health service to work together to deliver access. The MS Society said in its report, “A lottery of treatment and care: MS services across Scotland and the UK”, which was published last year:
“Only 36 per cent of people living with MS in Scotland who are eligible take medicines that alter the course of MS.”
It went on to say:
“29 per cent of people in Scotland told us they do not have enough information about medicines.”
That brings me to the people and families who deal with MS on a daily basis. The MS Society in Scotland decided to gather evidence on what its membership and people in Scotland are doing. It went to Inverness, Airdrie, Edinburgh, Hamilton, Aberdeenshire and Dunfermline to speak to people, and it found that the big issue is access to the drugs that people need. One woman said that she had been on—excuse my pronunciation—Tysabri for five years and it had made a huge difference to her. She said, “Although the treatment clinic I go to is quite a distance away, I see my MS specialist regularly, but this is partly because of the treatment I’m on—there might be side effects.”
Another woman said, “When planning my life and business, I don’t need to worry about fridges for my syringes because now I’m on Gilenya, which is a tablet.” She said that she could just keep the drug in her handbag. She has access to dedicated staff, but she said that she worried about whether other individuals had similar access.
I will mention a wee wifie from Paisley who I speak to on the High Street, Rosemary Thompson—she is Stacey’s mum, incidentally. She says that it is important that people with MS get more support and more access to MS professionals from an early stage. She also thinks that GPs should be better informed. We constantly hear from people with MS that their GPs do not have the full information.
Therapy centres such as the Revive MS Support centre, in Glasgow, offer the best support. Often, what is needed is someone to listen and talk to people and the opportunity to get further information.
We have been lucky. Stacey had a problem with her mobility but got physiotherapy only after she had a fall—at that point, after having had MS for 20 years, she was taught how to walk with crutches. That kind of support should be happening at an earlier stage.
Elizabeth Quigley talked last night about how she wants progress on access to drugs. There is a two-way street: the drugs companies must make applications to the Scottish Medicines Consortium if we are to be able to get the drugs. Fampyra has been licensed since 2012 and Sativex since 2010, but nothing has been done with those drugs yet.
We have to ensure that those drugs are available, because they can make a difference in people’s lives. At last week’s meeting of the cross-party group, Stacey said, “It’s like someone showing you a new designer house but not giving you the keys—you just look at it for five years.” She also said that not giving access to the drugs is “evil”.
That is an important point, because in Scotland we have more MS sufferers per head of population than anywhere else does. It is a very Scottish disease. We say that 11,000 people in Scotland are dealing with MS, but we do not know for sure. I ask the cabinet secretary to look at extending reporting for the Scottish MS register, which was launched in 2010. Currently, only people who are newly diagnosed with multiple sclerosis are registered. We need to expand the register so that everyone in Scotland who has MS is on it. Only when we know exactly how many people there are and where they are can we plan for prescribing and treatment.
Only when we start to do the things that I have talked about will we start to treat people with MS right.